Literature DB >> 25468188

Overlapping auditory M100 and M200 abnormalities in schizophrenia and bipolar disorder: a MEG study.

Ying Wang1, Yanbin Jia2, Yigang Feng3, Shuming Zhong2, Yanping Xie3, Wensheng Wang3, Yufang Guan3, Dan Zhu3, Li Huang4.   

Abstract

OBJECTIVES: Schizophrenia and bipolar disorder share common etiological factors and pathophysiological pathways and have overlapping clinical features. Only few studies have directly compared early auditory information processing in the two disorders. The objective of this study was to investigate the M100 and M200 auditory responses in patients with schizophrenia and bipolar disorder and compare them with healthy controls using magnetoencephalography (MEG).
METHODS: Whole-head MEG data were acquired during an auditory oddball paradigm in 24 schizophrenia patients, 26 bipolar I disorder patients, and 31 healthy controls. The strengths and latencies of M100 and M200 in both hemispheres and the dipole source localizations were investigated from the standard stimuli.
RESULTS: The M100 and M200 dipolar sources were localized to the left and right posterior portion of the superior temporal gyrus (STG) in all the subjects. An asymmetric pattern of M100 and M200 auditory response with more anterior sources in the right STG was observed in the healthy controls. However, both the schizophrenia and bipolar disorder patients showed a symmetric M100 and M200 source pattern. When compared with the healthy control group, both patient groups showed significantly reduced M100 and M200 source strength in both hemispheres.
CONCLUSIONS: Our study suggests that early auditory information processing deficits may be similar in schizophrenia and bipolar disorder and may be related to abnormalities of the STG.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Bipolar disorder; M100; M200; Magnetoencephalography; Schizophrenia

Mesh:

Year:  2014        PMID: 25468188     DOI: 10.1016/j.schres.2014.10.042

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  6 in total

1.  Auditory evoked response delays in children with 47,XYY syndrome.

Authors:  Luke Bloy; Matthew Ku; J Christopher Edgar; Judith S Miller; Lisa Blaskey; Judith Ross; Timothy P L Roberts
Journal:  Neuroreport       Date:  2019-05-01       Impact factor: 1.837

2.  Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.

Authors:  Hamid M Abdolmaleky; Adam C Gower; Chen-Khuan Wong; Jiayi W Cox; Xiaoling Zhang; Arunthathi Thiagalingam; Rahim Shafa; Vadivelu Sivaraman; Jin-Rong Zhou; Sam Thiagalingam
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2018-11-23       Impact factor: 3.568

3.  Auditory steady-state EEG response across the schizo-bipolar spectrum.

Authors:  David A Parker; Jordan P Hamm; Jennifer E McDowell; Sarah K Keedy; Elliot S Gershon; Elena I Ivleva; Godfrey D Pearlson; Matcheri S Keshavan; Carol A Tamminga; John A Sweeney; Brett A Clementz
Journal:  Schizophr Res       Date:  2019-05-09       Impact factor: 4.939

4.  Subcomponents of brain T2* relaxation in schizophrenia, bipolar disorder and siblings: A Gradient Echo Plural Contrast Imaging (GEPCI) study.

Authors:  Daniel Mamah; Jie Wen; Jie Luo; Xialing Ulrich; Deanna M Barch; Dmitriy Yablonskiy
Journal:  Schizophr Res       Date:  2015-10-23       Impact factor: 4.939

Review 5.  Visual Influences on Auditory Behavioral, Neural, and Perceptual Processes: A Review.

Authors:  Collins Opoku-Baah; Adriana M Schoenhaut; Sarah G Vassall; David A Tovar; Ramnarayan Ramachandran; Mark T Wallace
Journal:  J Assoc Res Otolaryngol       Date:  2021-05-20

6.  Common and specific patterns of functional and structural brain alterations in schizophrenia and bipolar disorder: a multimodal voxel-based meta-analysis.

Authors:  Zhangzhang Qi; Junjing Wang; Jiaying Gong; Ting Su; Siying Fu; Li Huang; Ying Wang
Journal:  J Psychiatry Neurosci       Date:  2022-02-01       Impact factor: 6.186

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.